Monoclonal antibody FDC-6 exhibits binding to human plasma fibronectin: A caveat for cervicovaginal oncofetal fibronectin testing?
- 1 November 1994
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 171 (5) , 1302-1308
- https://doi.org/10.1016/0002-9378(94)90152-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Transforming growth factor-beta stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivoJournal of Clinical Endocrinology & Metabolism, 1994
- Fetal fibronectin in patients at increased risk for premature birthAmerican Journal of Obstetrics and Gynecology, 1994
- The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric populationAmerican Journal of Obstetrics and Gynecology, 1993
- Steroid regulation of oncofetal fibronectin expression in human cytotrophoblastsThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Preterm birth prevention: Where are we?American Journal of Obstetrics and Gynecology, 1993
- Circulating concentrations of fetal fibronectin do not reflect reduced trophoblastic invasion in preeclamptic pregnanciesAmerican Journal of Obstetrics and Gynecology, 1992
- Fetal Fibronectin and Preterm LaborNew England Journal of Medicine, 1992
- 1 Oncofetal Fibronectin in Patients at Increased Risk for Preterm DeliveryAmerican Journal of Obstetrics and Gynecology, 1992
- Fetal Fibronectin in Cervical and Vaginal Secretions as a Predictor of Preterm DeliveryNew England Journal of Medicine, 1991
- Binding of soluble form of fibroblast surface protein, fibronectin, to collagenInternational Journal of Cancer, 1977